Lupus
New Treatment Guideline for Lupus Nephritis Shifts Focus to Continuous Therapy
The ACR has released an updated guideline for the screening, treatment and management of lupus nephritis to ...
MAY 15, 2025

Does Lack of Pain Mean Lack of Complications for Patients With Lupus?
Published data indicate that for patients who have lupus, monitoring for kidney disease—even in the absence ...
JULY 2, 2024

Novel Biomarkers Used to Identify Patients With Renal Lupus
Recently published research showcased the use of a technique called proximity extension assay (PEA) to identify ...
FEBRUARY 22, 2024

FDA Approves Saphnelo, First New Treatment for Lupus in 10 Years
This marks the first regulatory approval for a type I interferon receptor antagonist, which plays a central role in ...
AUGUST 4, 2021

Anifrolumab Infusion Reduces SLE Joint Disease, Tenderness and Rash
A post hoc analysis of pooled phase 3 clinical trial data has found anifrolumab-fnia reduced joint disease and ...
JULY 15, 2021

Not Enough RA and Lupus Drugs During Early Days of COVID-19
A shortage of hydroxychloroquine and methotrexate led to an increase in symptoms among patients in the Philippines ...
JULY 8, 2021

ACR Urges COVID-19 Vaccination of Rheumatology Patients
The American College of Rheumatology recommends the vaccination of rheumatology patients with musculoskeletal, ...
MARCH 1, 2021

New Estimates Show More Accurate Representation of SLE in the U.S.
Systemic lupus erythematosus is an uncommon disease and can be somewhat difficult to diagnose. Its range and ...
FEBRUARY 5, 2021

Researchers Discover Possible Pathway of Vagus Nerve’s Inflammatory Response
New research has discovered that the vagus nerve’s dorsal motor nucleus may be the point of action of the ...
NOVEMBER 11, 2020

Communication Is Key During Pandemic
A well-executed communication approach has been key to coping with the first wave of the COVID-19 pandemic, experts ...
SEPTEMBER 29, 2020

Studies: Most SLE, Arthritis Patients Not at Higher Risk for COVID Hospitalization
Patients with systemic lupus erythematosus or inflammatory arthritis conditions such as rheumatoid arthritis may ...
SEPTEMBER 25, 2020

Use as COVID-19 Treatment Worsens Hydroxychloroquine Shortages for Rheumatology Patients
A run on a rheumatology drug increasingly being used as a treatment for COVID-19 has led to panic in the lupus and ...
MAY 5, 2020
